A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
Kanye West reignited his feud with Adidas, his former partner in his Yeezy shoe brand, accusing the company of “design theft and oppression” and making “moves to hold me back,” in an ...
While Kanye West has hardly visited the US in the last eight months, his ex-Kim Kardashian and their four kids left their residence in Calabasas, California. Kanye West's ex-wife Kim Kardashian ...
The trailer for Hilaria and Alec Baldwin's new TLC reality show "The Baldwins" addresses the fallout from the fatal "Rust" ...
A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...
By Isabel Kershner To report this article, Isabel Kershner and the photographer Avishag Shaar-Yashuv visited the settlements of Shilo and Eli in the occupied West Bank. Eliana Passentin delights ...
For the first time in two decades, the FDA has approved a new class of non-opioid pain medication, offering an alternative to addictive opioids for patients seeking pain relief. The drug ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of ...